US Task Force advises against use of HRT

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.386, 2002-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recommendations against the use of betacarotene supplements for the prevention of cardiovascular disease or cancer have been published by the US Preventive Services Task Force

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 431, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

The US FDA advises against filling prescriptions outside of the US due to the risk of being given the wrong drug.

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 495, 2006-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

US FDA advises caution for recombinant erythropoietins

By  

Inpharma, Vol. 1, Iss. 1565, 2006-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

US FDA advises caution for recombinant erythropoietins

By  

Reactions Weekly, Vol. 1, Iss. 1129, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Restrictions on rosiglitazone use come into force in the US

By  

Reactions Weekly, Vol. 1, Iss. 1353, 2011-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite